LORRIE BALL: Open Payments
NPI 1144982430 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 32 payments from 13 companies in 2025. Trend: 2023 $423 · 2024 $633 · 2025 $735
Food & beverage: $734Education: $2
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| Novo Nordisk Inc | 4 | $100 |
| Calliditas Therapeutics US Inc. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Travere Therapeutics, Inc. | 3 | $46 |
| Ardelyx, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| AKEBIA THERAPEUTICS INC | 1 | $30 |
Products named: FARXIGA, TARPEYO, LOKELMA, JYNARQUE, Ozempic, ACTHAR, IBSRELA, Kerendia.
Industry payments across GA — which companies pay providers there.
